Boothbay Fund Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,570
|
|
||||
|
2023
Q2 | $312K | Buy |
30,570
+14,167
|
|
||||
|
2023
Q1 | $149K | Buy |
16,403
+2,450
|
|
||||
|
2022
Q4 | $100K | Sell |
13,953
-26,798
|
|
||||
|
2022
Q3 | $266K | Sell |
40,751
-44,711
|
|
||||
|
2022
Q2 | $412K | Sell |
85,462
-1,173
|
|
||||
|
2022
Q1 | $492K | Hold |
86,635
|
|
||||
|
2021
Q4 | $435K | Hold |
86,635
|
|
||||
|
2021
Q3 | $576K | Sell |
86,635
-38,192
|
|
||||
|
2021
Q2 | $763K | Sell |
124,827
-9,689
|
|
||||
|
2021
Q1 | $895K | Sell |
134,516
-16,183
|
|
||||
|
2020
Q4 | $797K | Sell |
150,699
-1,542
|
|
||||
|
2020
Q3 | $1.13M | Buy |
152,241
+30
|
|
||||
|
2020
Q2 | $1.12M | Buy |
152,211
+36,823
|
|
||||
|
2020
Q1 | $854K | Buy |
+115,388
|
|